These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25691345)

  • 1. [Risk stratification for sudden cardiac death].
    Bonnemeier H; Potratz J
    Herzschrittmacherther Elektrophysiol; 2015 Mar; 26(1):3-4. PubMed ID: 25691345
    [No Abstract]   [Full Text] [Related]  

  • 2. [35 year ICD therapy: Where does it come from and where does it go?].
    Israel CW
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):59-60. PubMed ID: 26031514
    [No Abstract]   [Full Text] [Related]  

  • 3. Why the Authors Use Cardiac Resynchronization Therapy with Defibrillators.
    Sze E; Daubert JP
    Card Electrophysiol Clin; 2015 Dec; 7(4):695-707. PubMed ID: 26596812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More.
    Daubert JC; Martins R; Leclercq C
    Card Electrophysiol Clin; 2015 Dec; 7(4):709-20. PubMed ID: 26596813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death in China.
    Zhang S
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1159-62. PubMed ID: 19719492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the cause of death of ICD patients during long-term follow-up].
    Fiek M; Zieg B; Matis T; Hahnefeld A; Reithmann C; Steinbeck G
    Herzschrittmacherther Elektrophysiol; 2006 Mar; 17(1):6-12. PubMed ID: 16547654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease.
    Alsheikh-Ali AA; Trikalinos TA; Ruthazer R; Terrin N; Wong JB; Sarnak MJ; Estes NA; Kent DM
    Am Heart J; 2011 Jan; 161(1):204-209.e1. PubMed ID: 21167355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardiac death risk stratification in patients with heart failure.
    Lorvidhaya P; Addo K; Chodosh A; Iyer V; Lum J; Buxton AE
    Heart Fail Clin; 2011 Apr; 7(2):157-74, vii. PubMed ID: 21439495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life versus death.
    Moss AJ
    Circulation; 2008 Apr; 117(15):1912-3. PubMed ID: 18413507
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden cardiac death. Preface.
    Weiss R; Daoud EG
    Heart Fail Clin; 2011 Apr; 7(2):xix-xx. PubMed ID: 21439493
    [No Abstract]   [Full Text] [Related]  

  • 13. Getting the most out of life.
    Schwartzman D
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1167-8. PubMed ID: 18631267
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heart failure with or without myocardial infarct. Which patient profits from defibrillator?].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Worldwide experience with automated external defibrillators: What have we achieved? What else can we expect?].
    Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2016 Mar; 27(1):31-7. PubMed ID: 26830774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillators for primary prevention of sudden death: the quest to identify patients most likely to benefit.
    Buxton AE
    J Am Coll Cardiol; 2012 Oct; 60(17):1656-8. PubMed ID: 23021332
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward more optimal use of primary prevention implantable cardioverter-defibrillators: how do we get there?
    Al-Khatib SM
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):140-2. PubMed ID: 21406668
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification for sudden death in heart failure.
    Farwell D; Gollob MH
    Minerva Cardioangiol; 2007 Jun; 55(3):379-84. PubMed ID: 17534256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy".
    Madias JE
    Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15900622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.